Anonymous
Guest
Anonymous
Guest
Better get those resumes fired up CCG reps. It is a tough world out there, especially for people who have only sold one product for many years.
The Merck management make the same mistake over and over. Merck simply cannot have a drug name start with letter V. Vioxx, Vytorin and now Vorapaxar. When I first saw the name Vorpaxar, I knew it's trouble.
Current CCG rep here. This is just par for the course for us. It seems like for the last number of years every major study has gone against us. I think it is time for us to all explore future options. This hurts but the writing is on the wall.
Well stated displaced ccg rep. The time for denial is over. Good ccg reps can and have made the jump to device jobs and other good positions. With tra seemingly in big trouble the time to explore other options is now. I know many from our group that are doing well out of pharma.
Not true. Ccg rep that has been here for a number of years and has numerous options in the device world. There are many reps that have stayed here by choice. Is it harder to move now? Yes, but ccg reps with great cath lab relationships can move
Not true. Ccg rep that has been here for a number of years and has numerous options in the device world. There are many reps that have stayed here by choice. Is it harder to move now? Yes, but ccg reps with great cath lab relationships can move
Yeah right. Any CCG rep thats still here has tried and failed to find a job elsewhere, thats why they're still here. They can try to "explore other options" but if they haven't been picked up by now odds are that they won't be in the near future. I suggest riding it out here at Merck until the next round of layoffs. At least that way they'll get a package.
There is no package after November 2011, at least the excellent Schering Plough package.
There is no package after November 2011, at least the excellent Schering Plough package.
what you talking about, Willis?
Fred Hassan, Carrie Cox and the other members of the SP Executive Team really took advantage of the Merckies. Just like they did to Pfizer! Sell the buying company a bunch of promise that has little backing, then let them take all the heat for all the misdeeds you have committed. TRA reminds me of Integrilin - Lots of bleeding with mild efficacy, especially when it's given to the wrong patients (i.e., those that didn't need it in the first place and had no labelled reason to receive it.)
ya think?????? Displaced CCG rep here, know exactly what you're talking about, trying to do damage control at every account. It happened with Nights & Weekends strategy and Early ACS? Glad I'm not in this mess anymore. Got a great medical device job, love it and doing really well. Good luck CCG, miss the old days